Quick Answer
Olema Pharmaceuticals, Inc. reported Total Assets of $533.43 million for fiscal year 2025.
Olema Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $533.43M | +18.3% |
| 2024 | $450.98M | +62.8% |
| 2023 | $276.94M | +28.4% |
| 2022 | $215.65M | -27.1% |
| 2021 | $295.94M | -13.6% |
| 2020 | $342.72M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $352.45M | +53.1% | -7.7% |
| June 30, 2025 | $382.00M | +50.1% | -6.7% |
| March 31, 2025 | $409.64M | +55.3% | -9.2% |
| December 31, 2024 | $450.98M | +62.8% | +95.9% |
| September 30, 2024 | $230.17M | -21.4% | -9.6% |
| June 30, 2024 | $254.56M | +43.3% | -3.5% |
| March 31, 2024 | $263.69M | +34.7% | -4.8% |
| December 31, 2023 | $276.94M | +28.4% | -5.4% |
- Olema Pharmaceuticals, Inc. showed an increase of +18.3% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Olema Pharmaceuticals, Inc.’s total assets has grown by 55.6% (from $342.72 million to $533.43 million).
- The most recent figure is from Olema Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: